---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-241886"
form_type: "8-K"
ticker: "RGEN"
cik: "0000730272"
company_name: "REPLIGEN CORP"
filed_at: "2023-09-26T23:59:59+00:00"
generated_at: "2026-06-10T09:02:41.853657+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Repligen to acquire Metenova for cash and equity; adds magnetic mixing technology

## Summary
- Metenova projected FY2023 revenue $24-25M; ~50 employees; magnetic mixers for bioprocess.
- Expected close Q4 2023; funded with ~$604M cash on hand (cash + equity consideration).
- Metenova expected to contribute $5M revenue in Q4 2023, $25-27M in 2024, 20-25% growth in 2025.
- Deal projected accretive to adjusted gross/operating margins in 2024 and adjusted EPS in 2025.
- Adds single-use MixOne platform; complements Repligen's fluid management and FlexBiosys bag business.

## SEC filing metadata
- accession: 0001193125-23-241886
- form_type: 8-K
- ticker: RGEN
- cik: 0000730272
- company_name: REPLIGEN CORP
- filed_at: 2023-09-26T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/730272/000119312523241886/0001193125-23-241886-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/730272/000119312523241886/d561194d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-241886
- JSON: https://secwatch.observer/filing/0001193125-23-241886.json
- Plain text: https://secwatch.observer/filing/0001193125-23-241886.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.